Pentwater Capital Management LP - ESPERION THERAPEUTICS INC NE ownership

ESPERION THERAPEUTICS INC NE's ticker is and the CUSIP is 29664W905. A total of 5 filers reported holding ESPERION THERAPEUTICS INC NE in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Pentwater Capital Management LP ownership history of ESPERION THERAPEUTICS INC NE
ValueSharesWeighting
Q2 2021$4,230,000
+373.2%
200,000
+1233.3%
0.04%
+133.3%
Q4 2019$894,000
-84.3%
15,000
-90.3%
0.02%
-83.1%
Q3 2019$5,682,000
-21.2%
155,0000.0%0.09%
+15.6%
Q2 2019$7,211,000
-14.5%
155,000
-15.5%
0.08%
+6.9%
Q4 2018$8,436,000
+258.8%
183,400
+205.7%
0.07%
+323.5%
Q2 2018$2,351,000
-80.7%
60,000
-67.6%
0.02%
-79.0%
Q4 2017$12,180,000
+35.0%
185,000
+2.8%
0.08%
+5.2%
Q3 2017$9,022,000
+387.4%
180,000
+350.0%
0.08%
+352.9%
Q2 2017$1,851,000
-47.6%
40,000
-60.0%
0.02%
-60.5%
Q1 2017$3,531,000100,0000.04%
Other shareholders
ESPERION THERAPEUTICS INC NE shareholders Q2 2021
NameSharesValueWeighting ↓
SIMPLEX TRADING, LLC 220$460,0000.05%
GROUP ONE TRADING, L.P. 10,000$926,0000.02%
Citadel Advisors 24,100$2,232,0000.00%
View complete list of ESPERION THERAPEUTICS INC NE shareholders